PharmaSGP Holding Stock

PharmaSGP Holding Dividend

The Dividend of PharmaSGP Holding (PSG.DE) as of Mar 12, 2026 is 0.85 EUR. In the previous year, Dividend was 1.36 EUR — a change of -37.27% (lower).

Dividend

0.85EUR

YoY

-37.27%

Dividend yield

1.7 %

Last updated: Mar 12, 2026

How much dividend does PharmaSGP Holding 2026 pay?

According to the latest status from March 2026, PharmaSGP Holding paid a total of 0.85 EUR per share in dividends within the last 12 months. With the current PharmaSGP Holding price of 28.8 EUR, this corresponds to a dividend yield of 2.96 %. A dividend is paid times per year.

Historical PharmaSGP Holding Dividends

A dividend is paid times per year. Last year, the payout months were and July.

PaydateDividend
7/26/20250.05
7/27/20241.36
7/29/20230.49
7/16/20220.45

PharmaSGP Holding dividend history and estimates

In 2025, PharmaSGP Holding paid a dividend amounting to 0.05 EUR. Dividend means that PharmaSGP Holding distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
0.45 EUR
0 EUR
Jan 1, 2023
0.49 EUR
0 EUR
Jan 1, 2024
1.36 EUR
0 EUR
Invalid Date
0 EUR
0.05 EUR
Invalid Date
0 EUR
0.98 EUR
API Docs Get API Key

Is the PharmaSGP Holding Dividend Safe?

PharmaSGP Holding has been increasing the dividend for 1 years.

Over the past 7 years, PharmaSGP Holding has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Increase of 83.316% for the current fiscal year.

PharmaSGP Holding dividend payout ratio

In 2025, PharmaSGP Holding had a payout ratio of 45.17%. The payout ratio indicates the percentage of the company's profits that PharmaSGP Holding distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
45.17 %
Jan 1, 2018
45.17 %
Jan 1, 2019
45.17 %
Jan 1, 2020
45.17 %
Jan 1, 2021
45.17 %
Jan 1, 2022
45.17 %
Jan 1, 2023
45.17 %
Invalid Date
45.17 %
Invalid Date
45.17 %
Invalid Date
45.17 %

Dividend Details

Understanding PharmaSGP Holding's Dividend Distributions

PharmaSGP Holding’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining PharmaSGP Holding's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

PharmaSGP Holding's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in PharmaSGP Holding’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

PharmaSGP Holding Stock analysis

What does PharmaSGP Holding do? PharmaSGP Holding SE is a leading European company specializing in the marketing of over-the-counter and natural pharmaceuticals. The company was founded in 2009 and is headquartered in Gräfelfing near Munich. The history of PharmaSGP began with the vision of founder and CEO Alexander Kurz, who believed that many people were looking for natural alternatives to pharmaceuticals. Kurz founded PharmaSGP with the goal of developing natural health products that help people improve their health and well-being. PharmaSGP's business model focuses on the marketing of over-the-counter and natural pharmaceuticals through pharmacies, drugstores, and online sales. The company has a strong presence in Europe and is also expanding into other regions worldwide. PharmaSGP is divided into three divisions: Consumer Healthcare, Medical Devices, and Healthcare Services. The Consumer Healthcare division offers natural health products and dietary supplements targeting consumers. The company has developed a wide range of products specifically tailored to the needs of people at different stages of life, from pregnancy and breastfeeding to old age. In the field of medical devices, PharmaSGP focuses on the development and marketing of innovative medical devices and technologies tailored to the needs of healthcare professionals. The company has developed a range of medical devices such as medication dispensers or blood glucose meters to facilitate disease treatment. In the Healthcare Services division, the company also offers services such as medical consulting and patient management. This involves holistic patient care, offering various services to ensure effective and comprehensive treatment. PharmaSGP also has an impressive range of products covering various health areas. There are products for dietary supplementation, sleep support, pain therapy, and cold relief, to name just a few. One of PharmaSGP's most well-known products is Yokebe, a natural meal replacement that can help reduce weight. The company is committed to ensuring the quality of its products and therefore works closely with scientists and healthcare professionals to ensure that all products are based on current scientific knowledge and studies. In summary, PharmaSGP is an innovative company focused on the marketing of natural and over-the-counter pharmaceuticals. It has developed a wide range of products and services specifically tailored to the needs of consumers and healthcare professionals. The company is committed to continuously improving the quality of its products and services and works closely with scientists and healthcare professionals to ensure comprehensive patient care. PharmaSGP Holding is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about PharmaSGP Holding stock

Over the past 12 months, PharmaSGP Holding paid a dividend of 0.49 EUR . This corresponds to a dividend yield of about 1.7 %. For the coming 12 months, PharmaSGP Holding is expected to pay a dividend of 0.85 EUR.

All Key Metrics — PharmaSGP Holding